Return to Archived Newletter Index | |
June 1995 | Vol. 3 Issue 11 |
IN THIS ISSUE: WORLDMED SINGLE ENTRY PATENT APPLICATION IS FILED FOR PROCELL". NEWSBITS. ANNOUNCEMENTS AND PRODUCT DEVELOPMENTS. EDITORIAL. SINGLE ENTRY Bi-Furcated Graft Placement System Design shared with Opinion Leaders! World Medical Manufacturing Corp. has come forward with what could be a breakthrough innovation in the field of endoluminal graft placement. The firm's new (patent pending) single entry bi-furcated graft placement system design (see enclosed insert of drawing) offers a simple method to handle a difficult problem. The design features a controllable deflecting tip guide wire and application of Worldmed's well known polyurethane balloon. The special guide wire and the flow directed balloon help guide the alternative leg of the graft material down the other vessel branch. The balloon provides an excellent circumferential fit to the inside of the leg of the graft material. This coupling is made in a safe manner avoiding graft damage and reducing the risk of vessel perforation compared to wire only systems. |
PATENT APPLICATION FILED FOR PRO-CELL" Localized site specific delivery of drugs, cells, enzymes and other substances is a growing field of interest. Numerous researchers are exploring new applications for this technology. World Medical Manufacturing Corporation is pursuing U.S. patent protection for a design which they believe will be more effective than previously disclosed systems. The PRO-CELL" features a controllable inflation polyurethane balloon at its core. A series of needles remain with a low entry profile inside the walls of the catheter until the balloon is inflated. The balloon controls the depth of needle penetration. The design was registered in Worldmed's Engineering Notebooks in early 1993.
Study Is Being Conducted To Obtain Rights To Continuous Cardiac Output Catheter Technology World Medical Manufacturing Corporation is reviewing the opportunity to obtain the exclusive manufacturing and marketing rights to a PATENTED device which the inventors claim offers true beat to beat continuous cardiac output monitoring technology. The technology is also distinctive since it will be less costly to produce than other known continuous cardiac output monitoring systems. The developers of this technology have already received 510K permission from the F.D.A. to begin marketing this device in the U.S.A. The technology is based on temperature differential. One thermistor is the constant and the other is energized to keep a balance with the first thermistor. The amount of energy required to keep the balance is interpreted as the cardiac output. |
TOP OF PAGE | NEXT PAGE |
|